Nakamoto, Inc. (NAKA)
5.00
-0.79
(-13.64%)
USD |
NASDAQ |
Nov 13, 16:00
4.93
-0.07
(-1.40%)
After-Hours: 19:59
Nakamoto Total Assets (Quarterly) : 517.19M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 517.19M |
| June 30, 2026 | 422.51M |
| March 31, 2026 | 620.76M |
| December 31, 2025 | 730.61M |
| September 30, 2025 | 692.42M |
| June 30, 2025 | 9.890M |
| March 31, 2025 | 2.564M |
| December 31, 2024 | 3.678M |
| Date | Value |
|---|---|
| September 30, 2024 | 4.324M |
| June 30, 2024 | 5.457M |
| March 31, 2024 | 0.7993M |
| December 31, 2023 | 1.099M |
| September 30, 2023 | 0.8563M |
| June 30, 2023 | 0.82M |
| March 31, 2023 | 1.108M |
| December 31, 2022 | 0.947M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Astrana Health, Inc. | 2.343B |
| Agilon Health, Inc. | 1.566B |
| Starling Oncology, Inc. | 187.77M |
| American Oncology Network, Inc. | -- |
| Biodesix, Inc. | 93.94M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 192.92M |
| Shareholders Equity (Quarterly) | 324.28M |
| Debt to Equity Ratio | 0.5084 |
| Current Ratio | 0.2278 |
| Net Debt Paydown Yield | -18.93% |